Skip to content

Hepato Biliary Scintigraphy to Assess the Risk of Postoperative Liver Failure Hepatectomies

Predictive Value of Hepato Biliary Scintigraphy to Assess the Risk of Postoperative Liver Failure Hepatectomies Stretches of 4 or More Segments on Non-cirrhotic Liver

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02753517
Acronym
SCINTIVOL
Enrollment
326
Registered
2016-04-28
Start date
2015-12-08
Completion date
2021-12-10
Last updated
2026-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic Insufficiency

Keywords

hepatobiliary scintigraphy, extended hepatectomy, volumetry

Brief summary

Extended hepatectomies of 4 or more segments are complicated by high rates of morbidity and mortality, mainly related to hepatic liver failure. Nowadays, preoperative assessment of the future remnant liver is just performed through its volumetric measurement by computed tomography. Nevertheless, this volumetric assessment does not reflect the hepatocellular function of the future remnant liver that can be disturbed in case of vascular and/or biliary obstruction, chemotherapy-induced liver injuries or steatosis in overweight patients. Literature data (albeit originating from a single centre in Europe) have suggested that (99m)Tc-mebrofenin hepatobiliary scintigraphy could be useful in evaluating the function of the future remnant liver. The aim of this prospective multicentric study is to determine the predictive value of hepatobiliary scintigraphy in assessing the risk of postoperative liver failure of extended hepatectomies of 4 or more segments in noncirrhotic liver.

Detailed description

The main aim of the study is to determine the predictive value of (99m)Tc-mebrofenin hepatobiliary scintigraphy in assessing the postoperative risk of liver failure within 3 months of extended hepatectomy of 4 or more segments in noncirrhotic liver. The main endpoint is the three-months postoperative liver failure, defined as an increased International Normalized Ratio (INR) and concomitant hyperbilirubinemia (according to the normal limits of the local laboratory) on or after postoperative day 5 according to the international classification of the ISGLS (International Study Group of Liver Surgery) and classified according to its severity in grade A (no change of the patient's clinical management), grade B (deviation from the regular course but without invasive therapy) and grade C (invasive treatment) Secondary objectives are: To determine the predictive value of (99m)Tc-mebrofenin hepatobiliary scintigraphy in assessing the risk of postoperative morbi-mortality (according to Clavien-Dindo classification) within 3 months of extended hepatectomy of 4 or more segments in noncirrhotic liver, and the duration of intensive care unit stay and of hospitalization. * To assess the correlation between the results of the hepatobiliary scintigraphy and the presence of parenchymal abnormalities such as steatosis, fibrosis or chemotherapy-induced injuries (sinusoidal obstruction syndrome, steatohepatitis) at the histological analysis of the non tumoral liver parenchyma. * To assess the sensitivity of hepatobiliary scintigraphy in jaundiced patients who had a preoperative biliary endoscopic or radiologic drainage, considering the existing competition between mebrofenin and bilirubin on hepatic receptors. * To analyse the inter-centre reproducibility of the hepatobiliary scintigraphy (Central review by the principal investigator of 25 scintigraphy examinations per centre)

Interventions

hepatobiliary scintigraphy with functional assessment of the future remnant liver before an extended hepatectomy of 4 or more segments

Sponsors

University Hospital, Lille
Lead SponsorOTHER
Ministry of Health, France
CollaboratorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Noncirrhotic liver * Benign or malignant liver tumor * Anatomic hepatic resection ≥ 4 segments * Aged ≥18 * ASA Score ≤3 * Signed informed consent * Presence of contraception in non-menopausal women

Exclusion criteria

* Cirrhosis * Absence of preoperative biliary drainage in case of preoperative jaundice * Patient refusal * Absence of affiliation to Social Security * Body weight above 230kg * Known allergy to Hida derivatives

Design outcomes

Primary

MeasureTime frameDescription
Hepatic insufficiencyat 3 monthsISGLS criteria : a definition and grading by the International Study Group of Liver Surgery (ISGLS)of the Posthepatectomy liver failure:

Secondary

MeasureTime frameDescription
Postoperative morbi-mortalityat 3 monthsClavien-Dindo classification
Duration of intensive care unit stay and of hospitalization3 monthsDuration of hospitalization
Histological analysis of the non tumoral liver parenchymaat 3 monthscorrelation of liver parenchymal abnormalities with the results of scintigraphy
Inter-centre reproducibility of the hepatobiliary scintigraphyat 3 monthsCentral review by the principal investigator of 25 scintigraphy examinations per centre

Countries

France

Contacts

PRINCIPAL_INVESTIGATORStéphanie Truant, MD

University Hospital, Lille

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 22, 2026